v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Income) Loss
Non-controlling Interest
Beginning balance (in shares) at Jan. 31, 2024   241,865        
Beginning balance at Jan. 31, 2024 $ 2,337,089 $ 121 $ 3,364,328 $ (1,058,836) $ (1,663) $ 33,139
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   300        
Issuance of common stock upon exercise of options 2,464   2,464      
Issuance of common stock under RSU and PSU release (in shares)   2,434        
Issuance of common stock under RSU and PSU release 0 $ 2 (2)      
Issuance of common stock under employee stock purchase plan (in shares)   518        
Issuance of common stock under employee stock purchase plan 56,099   56,099      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   5        
Issuance of common stock for founders holdbacks related to acquisitions 1,778   1,778      
Issuance of common stock for payment of board of director fees 175   175      
Stock-based compensation expense, net of founder revest 380,109   380,109      
Capitalized stock-based compensation 19,478   19,478      
Fair value of replacement equity awards attributable to pre-acquisition service 468   468      
Net income (loss) 92,954     89,833   3,121
Non-controlling interest 1,415         1,415
Other comprehensive income (loss) (1,439)       (1,439)  
Ending balance (in shares) at Jul. 31, 2024   245,122        
Ending balance at Jul. 31, 2024 2,890,590 $ 123 3,824,897 (969,003) (3,102) 37,675
Beginning balance (in shares) at Apr. 30, 2024   243,184        
Beginning balance at Apr. 30, 2024 2,568,782 $ 122 3,556,194 (1,016,016) (4,760) 33,242
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   208        
Issuance of common stock upon exercise of options 1,641   1,641      
Issuance of common stock under RSU and PSU release (in shares)   1,210        
Issuance of common stock under RSU and PSU release 0 $ 1 (1)      
Issuance of common stock under employee stock purchase plan (in shares)   518        
Issuance of common stock under employee stock purchase plan 56,099   56,099      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   2        
Issuance of common stock for founders holdbacks related to acquisitions 889   889      
Issuance of common stock for payment of board of director fees 87   87      
Stock-based compensation expense, net of founder revest 198,476   198,476      
Capitalized stock-based compensation 11,512   11,512      
Net income (loss) 46,690     47,013   (323)
Non-controlling interest 4,756         4,756
Other comprehensive income (loss) 1,658       1,658  
Ending balance (in shares) at Jul. 31, 2024   245,122        
Ending balance at Jul. 31, 2024 2,890,590 $ 123 3,824,897 (969,003) (3,102) 37,675
Beginning balance (in shares) at Jan. 31, 2025   247,872        
Beginning balance at Jan. 31, 2025 $ 3,318,917 $ 124 4,367,070 (1,078,107) (9,593) 39,423
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares) 265 265        
Issuance of common stock upon exercise of options $ 2,355   2,355      
Issuance of common stock under RSU and PSU release (in shares)   2,402        
Issuance of common stock under RSU and PSU release 0 $ 1 (1)      
Issuance of common stock under employee stock purchase plan (in shares)   275        
Issuance of common stock under employee stock purchase plan 74,622   74,622      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   13        
Issuance of common stock for founders holdbacks related to acquisitions 6,136   6,136      
Issuance of common stock for payment of board of director fees 176   176      
Stock-based compensation expense, net of founder revest 537,755   537,755      
Capitalized stock-based compensation 28,431   28,431      
Net income (loss) (188,638)     (187,882)   (756)
Non-controlling interest (656)         (656)
Other comprehensive income (loss) 15,593       15,593  
Ending balance (in shares) at Jul. 31, 2025   250,827        
Ending balance at Jul. 31, 2025 3,794,691 $ 125 5,016,544 (1,265,989) 6,000 38,011
Beginning balance (in shares) at Apr. 30, 2025   249,074        
Beginning balance at Apr. 30, 2025 3,491,014 $ 125 4,633,211 (1,188,314) 5,855 40,137
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   191        
Issuance of common stock upon exercise of options 1,721   1,721      
Issuance of common stock under RSU and PSU release (in shares)   1,274        
Issuance of common stock under RSU and PSU release 0          
Issuance of common stock under employee stock purchase plan (in shares)   275        
Issuance of common stock under employee stock purchase plan 74,622   74,622      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   13        
Issuance of common stock for founders holdbacks related to acquisitions 6,136   6,136      
Issuance of common stock for payment of board of director fees 88   88      
Stock-based compensation expense, net of founder revest 285,626   285,626      
Capitalized stock-based compensation 15,140   15,140      
Net income (loss) (77,645)     (77,675)   30
Non-controlling interest (2,156)         (2,156)
Other comprehensive income (loss) 145       145  
Ending balance (in shares) at Jul. 31, 2025   250,827        
Ending balance at Jul. 31, 2025 $ 3,794,691 $ 125 $ 5,016,544 $ (1,265,989) $ 6,000 $ 38,011